AKKARAJU SRINIVAS

CIK 1253170
Transactions on file
44
Open-market buys
33
Win rate (buys)
55%
33 scored
Avg % since filing (buys)
+7.8%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-09-102026-09-08ALMS
ALUMIS INC.
Buy273,290$2.90M-33.2%open →
2026-09-102026-09-08ALMS
ALUMIS INC.
Buy273,291$2.90M-33.2%open →
2026-09-102026-09-08ALMS
ALUMIS INC.
Sale48,065$507.0K-32.7%open →
2026-09-102026-09-08ALMS
ALUMIS INC.
Sale48,066$507.0K-32.7%open →
2026-09-102026-09-04ALMS
ALUMIS INC.
Buy220,070$2.46M-36.5%open →
2026-09-102026-09-04ALMS
ALUMIS INC.
Buy220,070$2.46M-36.5%open →
2026-06-082026-06-04SRRK
Scholar Rock Holding Corp
Director
Grant6,839$0.00—open →
2026-05-222026-05-20KLRS
Kalaris Therapeutics, Inc.
Other4,471$0.00—open →
2026-05-222026-05-20KLRS
Kalaris Therapeutics, Inc.
Other14,937$0.00—open →
2026-05-222026-05-20KLRS
Kalaris Therapeutics, Inc.
Other66,906$0.00—open →
2026-05-222026-05-20KLRS
Kalaris Therapeutics, Inc.
Buy244,300$1.18M-39.5%open →
2025-03-172025-03-13MLYS
Mineralys Therapeutics, Inc.
Director
Buy600,000$8.10M+91.6%open →
2025-03-182025-03-18KLRS
Kalaris Therapeutics, Inc.
Director10%
Grant11,444,503——open →
2025-05-062025-05-05ALMS
ALUMIS INC.
Director
Buy138,368$633.7K+55.0%open →
2025-05-062025-05-02ALMS
ALUMIS INC.
Director
Buy159,920$727.6K+56.0%open →
2025-05-062025-05-05ALMS
ALUMIS INC.
Director
Buy22,002$116.0K+34.7%open →
2025-05-232025-05-22SRRK
Scholar Rock Holding Corp
Director
Grant7,632$0.00—open →
2025-05-232025-05-21ALMS
ALUMIS INC.
Director
Grant1,214,582——open →
2025-12-162025-12-12SRRK
Scholar Rock Holding Corp
X1,064,804$7.83M+561.6%open →
2025-12-162025-10-07SRRK
Scholar Rock Holding Corp
Buy4,403$180.4K+18.7%open →
2025-12-162025-10-07SRRK
Scholar Rock Holding Corp
Buy12,400$498.2K+21.0%open →
2025-12-162025-10-07SRRK
Scholar Rock Holding Corp
Buy12,796$503.0K+23.7%open →
2025-12-092025-12-05ALMS
ALUMIS INC.
Buy51,380$551.3K-33.8%open →
2025-12-092025-12-05ALMS
ALUMIS INC.
Buy70,028$701.0K-29.1%open →
2025-12-092025-12-05ALMS
ALUMIS INC.
Buy64,969$581.5K-20.7%open →
2025-12-042025-12-04ALMS
ALUMIS INC.
Buy66,027$540.1K-13.2%open →
2025-12-042025-12-03ALMS
ALUMIS INC.
Buy100,000$775.0K-8.4%open →
2025-12-042025-12-02ALMS
ALUMIS INC.
Buy96,000$724.8K-6.0%open →
2025-12-012025-12-01ALMS
ALUMIS INC.
Buy86,350$644.2K-4.8%open →
2025-12-012025-11-28ALMS
ALUMIS INC.
Buy38,702$295.7K-7.1%open →
2025-12-012025-11-26ALMS
ALUMIS INC.
Buy48,537$370.8K-7.1%open →
2025-11-242025-11-20ALMS
ALUMIS INC.
Buy125,743$905.3K-1.4%open →
2025-11-192025-11-19ALMS
ALUMIS INC.
Buy137,772$903.8K+8.2%open →
2025-11-192025-11-18ALMS
ALUMIS INC.
Buy102,652$621.0K+17.4%open →
2025-11-192025-11-17ALMS
ALUMIS INC.
Buy914$5.0K+28.9%open →
2025-11-172025-11-13ALMS
ALUMIS INC.
Buy276,179$1.45M+35.2%open →
2025-10-072025-10-06SRRK
Scholar Rock Holding Corp
Buy13,748$543.3K+23.1%open →
2025-10-072025-10-06SRRK
Scholar Rock Holding Corp
Buy80,863$3.13M+25.7%open →
2025-10-072025-10-06SRRK
Scholar Rock Holding Corp
Buy18,414$697.7K+28.3%open →
2025-10-072025-10-03SRRK
Scholar Rock Holding Corp
Buy319,700$11.96M+30.0%open →
2025-10-072025-10-03SRRK
Scholar Rock Holding Corp
Buy56,703$2.08M+32.4%open →
2025-10-072025-10-03SRRK
Scholar Rock Holding Corp
Buy11,011$392.1K+36.6%open →
2025-09-082025-09-04MLYS
Mineralys Therapeutics, Inc.
Director
Buy588,235$15.00M+1.4%open →
2025-09-252025-09-22VTVT
vTv Therapeutics Inc.
Director
Grant106,000$1.62M+103.1%open →